Paradigm Biopharmaceuticals: Director’s Shareholding Update
Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Paradigm Biopharmaceuticals Ltd. has announced a change in the director’s securities holdings, with Paul Rennie disposing of 197,355 fully paid ordinary shares. Despite this reduction, Rennie continues to hold a significant number of shares across various accounts. This move could attract attention from investors watching director trading activities in the company.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
Trending Articles
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.